| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.26 | 0.4 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.25 | 5e-07 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.22 | 0.001 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.14 | 0.09 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |